Dioxin and Keratinocyte Differentiation
Dioxin and Keratinocyte Differentiation
批准号:
6686372
负责人:
Hollie Isabel Swanson
金额:
$28.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-04 至 2006-11-30
关键词:
aromatic hydrocarbon receptorcarcinogenesiscell differentiationcell growth regulationcell linecell proliferationchemical structure functiondioxinsenvironment related neoplasm /cancerenvironmental contaminationflow cytometrygene environment interactiongene induction /repressiongenetic regulationgreen fluorescent proteinsintermolecular interactionkeratinocytemicroarray technologymolecular pathologyneoplasm /cancer geneticspolymerase chain reactionreceptor couplingtime resolved datatranscription factortumor suppressor proteinswestern blottings
中文摘要
名称(申请人提供):2,3,7,8,四氯二苯并对二恶英
TCDD是一种普遍存在的促进肿瘤的环境污染物
形成和调节细胞分化,通过被认为涉及
芳香烃受体(AHR)信号通路。鉴于这项研究
角质形成细胞分化已被证明为研究
肿瘤促进剂发挥作用的机制(S)及该模型
适用于许多分子技术,我们已经启动了对
差异化以实现我们理解TCDD作用的长期目标
在致癌方面。使用正常的人类角质形成细胞(NHK),我们已经证明
TCDD对NHK细胞的最终抑制作用
分化,这种影响伴随着降低的水平
肿瘤抑制蛋白,p27Kipl,使用ARR拮抗剂的额外研究,
3‘-甲氧基-4’-硝基-黄酮类AHR在介导TCDD中的作用
抑制分化。最后,很明显,TCDD抑制了
通过减少分化细胞的数量进行分化,同时
增加未分化细胞的数量。这些结果和其他结果,
形成了我们总体假设的基础,即TCDD抑制的能力
分化是通过降低肿瘤的表达水平来调节的。
抑制蛋白p27Kipl从而抑制p27Kipl的分化
信号。为了验证这一假设,我们将使用流式细胞术、蛋白质印迹
分析、实时聚合酶链式反应和腺病毒介导的过表达系统
确定:1)TCDD抑制分化的能力是否需要
抑制p27Kipl的表达,2)TCDD对p27Kipl蛋白的调节
在转录或转录后水平,3)TCDD的能力
抑制p27Kipl的表达和分化需要AHR和
Arnt蛋白,4)TCDD抑制分化导致增加)
增殖;5)TCDD的分化作用发生在
基因组水平。
英文摘要
DESCRIPTION (provided by applicant): 2,3,7,8,Tetrachlorodibenzo-p-dioxin
\(TCDD\) is a ubiquitous environmental contaminant that promotes tumor
formation and modulates cellular differentiation via actions thought to involve
the aryl hydrocarbon receptor (AHR) signaling pathway. Given that study of
keratinocyte differentiation has been shown to lend important insights into the
mechanism(s) by which tumor promoters exert their effects and that this model
is amenable to a number of molecular techniques, we have initiated studies of
differentiation to fulfill our long-term goal of understanding the role of TCDD
in carcinogenesis. Using normal human keratinocytes (NHK), we have shown that
administration of TCDD to NHK cells ultimately results in suppression of
differentiation and that this effect is accompanied by decreased levels of the
tumor suppressor protein, p27Kipl Additional studies using the ARR antagonist,
3'-methoxy-4'nitroflavone implied a role of the AHR in mediating TCDD's
suppression of differentiation. Finally, it is apparent that TCDD suppresses
differentiation by decreasing the number of differentiating cells while
increasing the number of non-differentiating cells. These results and others,
form the basis of our overall hypothesis that the ability of TCDD to suppress
differentiation is mediated by a decrease in the expression levels of the tumor
suppressor protein, p27Kipl thereby diminishing the p27Kipl differentiation
signal. To test this hypothesis, we will use flow cytometry, western blot
analysis, real time PCR and adenovirus-mediated over expression systems to
determine whether: 1) the ability of TCDD to suppress differentiation requires
suppression of the expression of p27Kipl, 2) TCDD regulates the p27Kipl protein
at the transcriptional or post-transcriptional levels, 3) the ability of TCDD
to suppress the expression of p27Kipl and differentiation requires the AHR and
ARNT proteins, 4) suppression of differentiation by TCDD results in increased)
proliferation, and 5) and the actions of TCDD on differentiation occur at the)
genomic level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Summer Research in Environmental Health Sciences
-
批准号:9925649
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2017
-
负责人:Hollie Isabel Swanson
-
依托单位:
Summer Research in Environmental Health Sciences
-
批准号:9248759
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2017
-
负责人:Hollie Isabel Swanson
-
依托单位:
Chemopreventive properties of aryl hydrocarbon receptor antagonists
-
批准号:7287691
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
Chemopreventive properties of aryl hydrocarbon receptor antagonists
-
批准号:7214449
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
AHR-Protac, a novel aryl hydrocarbon receptor antagonist
-
批准号:7645021
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
AHR-Protac, a novel aryl hydrocarbon receptor antagonist
-
批准号:7448594
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
AHR-Protac, a novel aryl hydrocarbon receptor antagonist
-
批准号:7880922
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
AHR-Protac, a novel aryl hydrocarbon receptor antagonist
-
批准号:7131082
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
AHR-Protac, a novel aryl hydrocarbon receptor antagonist
-
批准号:7271398
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2006
-
负责人:Hollie Isabel Swanson
-
依托单位:
Dioxin and Keratinocyte Differentiation
-
批准号:7001345
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2002
-
负责人:Hollie Isabel Swanson
-
依托单位:
Dioxin and Keratinocyte Differentiation
-
批准号:6418451
-
项目类别:
-
资助金额:$28.4万
-
财政年份:2002
-
负责人:Hollie Isabel Swanson
-
依托单位:
Dioxin and Keratinocyte Differentiation
-
批准号:6830716
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2002
-
负责人:Hollie Isabel Swanson
-
依托单位:
Dioxin and Keratinocyte Differentiation
-
批准号:6620512
-
项目类别:
-
资助金额:$28.4万
-
财政年份:2002
-
负责人:Hollie Isabel Swanson
-
依托单位:
CONVERGENCE OF TCDD GENE ACTIVATION WITH OTHER PATHWAYS
-
批准号:2749690
-
项目类别:
-
资助金额:$10.27万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
Convergence of TCDD Gene Activation with Other Pathways
-
批准号:6625953
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
Convergence of TCDD Gene Activation with Other Pathways
-
批准号:6480497
-
项目类别:
-
资助金额:$31.46万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
Convergence of TCDD Gene Activation with Other Pathways
-
批准号:7039238
-
项目类别:
-
资助金额:$39.19万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
CONVERGENCE OF TCDD GENE ACTIVATION WITH OTHER PATHWAYS
-
批准号:2157545
-
项目类别:
-
资助金额:$9.5万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
Convergence of TCDD Gene Activation with Other Pathways
-
批准号:7147730
-
项目类别:
-
资助金额:$7.02万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
Convergence of TCDD Gene Activation with Other Pathways
-
批准号:6877795
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1996
-
负责人:Hollie Isabel Swanson
-
依托单位:
国内基金
海外基金
RKTG对ERK信号通路的调控和肿瘤生成的影响
-
批准号:30830037
-
项目类别:重点项目
-
资助金额:190.0万元
-
批准年份:2008
-
负责人:陈雁
-
依托单位: